Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study

BACKGROUNDS: Glucagon-like peptide-1 receptor agonist (GLP-1 RA) is probably one of more effective antidiabetic agents in treatment of type 2 diabetes mellitus (T2D). However, the heterogenicity in responses to GLP-1 RA may be potentially related to gut microbiota, although no human evidence has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Chih-Yiu, Lu, Hsiu-Chen, Chou, Yu-Hsien, Liu, Po-Yu, Chen, Hsin-Yun, Huang, Meng-Chuan, Lin, Chia-Hung, Tsai, Chi-Neu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793908/
https://www.ncbi.nlm.nih.gov/pubmed/35095773
http://dx.doi.org/10.3389/fendo.2021.814770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793908/
https://www.ncbi.nlm.nih.gov/pubmed/35095773
http://dx.doi.org/10.3389/fendo.2021.814770

Ejemplares similares